Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Dawson

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trialsN A Dawson
Current Oncology Reports|December 21, 2000
Intermittent androgen deprivationN A Dawson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Epothilones in prostate cancer: review of clinical experienceN A Dawson
Seminars in Oncology|December 22, 1999
Response criteria in prostatic carcinomaN A Dawson
Oncology (Williston Park, N.Y.)|May 1, 1993
Treatment of progressive metastatic prostate cancerN A Dawson
Oncology (Williston Park, N.Y.)|February 12, 1998
Management of progressive metastatic prostate cancerJ K Waselenko, N A Dawson
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
The assessment of treatment outcomes in metastatic prostate cancer: changing endpointsN A Dawson, D G McLeod
The Journal of Urology|June 1, 1995
Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndromeN A Dawson, D G McLeod
Expert Review of Anticancer Therapy|July 13, 2002
New agents for the treatment of renal cell carcinomaG G Tian, N A Dawson
Journal of the American Academy of Dermatology|February 1, 1988
AngioendotheliomatosisT G Berger, N A Dawson
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trialsN A Dawson
Current Oncology Reports|December 21, 2000
Intermittent androgen deprivationN A Dawson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Epothilones in prostate cancer: review of clinical experienceN A Dawson
Seminars in Oncology|December 22, 1999
Response criteria in prostatic carcinomaN A Dawson
Oncology (Williston Park, N.Y.)|May 1, 1993
Treatment of progressive metastatic prostate cancerN A Dawson
Oncology (Williston Park, N.Y.)|February 12, 1998
Management of progressive metastatic prostate cancerJ K Waselenko, N A Dawson
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
The assessment of treatment outcomes in metastatic prostate cancer: changing endpointsN A Dawson, D G McLeod
The Journal of Urology|June 1, 1995
Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndromeN A Dawson, D G McLeod
Expert Review of Anticancer Therapy|July 13, 2002
New agents for the treatment of renal cell carcinomaG G Tian, N A Dawson
Journal of the American Academy of Dermatology|February 1, 1988
AngioendotheliomatosisT G Berger, N A Dawson
Pageof 4